Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 3/20 | 0.40 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4957989 | 0.79 | ACHE (0.39) | P2RX4ACHEBCHEHPGDATM | |
| Bromide SCHEMBL27613563 | 0.77 | ACHE (0.44) | P2RX4ACHEBCHEHPGDATM | |
| SCHEMBL27586606 | 0.77 | BCHE (0.42) | ACHEBCHEHPGDALDH1A1KMT2A | |
| SCHEMBL28065316 | 0.77 | — | — | |
| SCHEMBL27472914 | 0.73 | GSK3B (0.42) | HPGDGSK3AGSK3BALDH1A1MAPT | |
| SCHEMBL27672167 | 0.63 | BCHE (0.48) | P2RX4ACHEBCHEHPGDSIGMAR1 | |
| SCHEMBL12256049 | 0.63 | TSHR (0.55) | P2RX4ACHEBCHEHPGDCHRNB2 | |
| SCHEMBL28405214 | 0.60 | HPGD (0.45) | P2RX4ACHEBCHEHPGDSIGMAR1 | |
| Benzoic Acid SCHEMBL28235721 | 0.60 | TSHR (0.82) | GSK3BALDH1A1MAPTCYP2C19TSHR | |
| SCHEMBL11792243 | 0.59 | P2RX4 (0.59) | P2RX4ACHEBCHEHPGDSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874775-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119841865-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119823184-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119343343-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-119343339-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-119255988-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119072474-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-118922189-A | Novel prodrugs derived from niacin and ribose | 线粒体能量有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-115698003-B | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-116615430-A | Heterocyclic GLP-1 agonists | 加舒布鲁姆生物公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-102112440-A | Heterocyclic compounds | TAKEDA PHARMACEUTICAL | 2011-06-29 | — | — | CN | disclosed |
| CN-102066328-A | Iminopyridine derivative and use thereof | TAKEDA PHARMACEUTICAL | 2011-05-18 | — | — | CN | disclosed |
| CN-102056907-A | Heterocyclic derivative and use thereof | TAKEDA PHARMACEUTICAL | 2011-05-11 | — | — | CN | disclosed |
| CN-102015641-A | Heterocyclic compound | TAKEDA PHARMACEUTICAL | 2011-04-13 | — | — | CN | disclosed |
| CN-101384251-A | Solid preparation containing insulin sensitizer | TAKEDA PHARMACEUTICAL (JP) | 2009-03-11 | — | — | CN | disclosed |
| CN-101151260-A | Benzimidazole derivative and use as angiotensin ii antagonist | TAKEDA PHARMACEUTICAL (JP) | 2008-03-26 | — | — | CN | disclosed |
| CN-1761465-A | Method for manufacturing coated formulation | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2006-04-19 | — | — | CN | disclosed |
| CN-1142778-C | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts | ¶ | 2004-03-24 | — | — | CN | disclosed |
| CN-1407975-A | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-04-02 | — | — | CN | disclosed |
| CN-1185736-A | Use of thiazolium compounds for preventing and preverting the formation of advanced glycosylation endproducts | ALTEON INC (US) | 1998-06-24 | — | — | CN | disclosed |